Elevated plasma prolactin concentration in essential hypertension
Kolloch, R.; Stumpe, K.O.; Higuchi, M.; Vetter, H.; Glänzer, K.; Krück, F.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 296-298
1977
ISSN/ISBN: 0070-4067 PMID: 611969 Document Number: 117305
Document emailed within 1 workday
Related Documents
Lechi, C.; Gaino, S.; Zuliani, V.; Tommasoli, R.M.; Faccini, G.; Fasson, R.; Arcaro, G.; Lechi, A.; Minuz, P. 2003: Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications International Angiology: a Journal of the International Union of Angiology 22(1): 72-78Brecht, H.M.; Vlachoyannis, J.; Musil, H.A.; Ernst, W.; Weismüller, G.; Schoeppe, W. 1975: Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1035-1038
Kucerová, V.; Peleska, J.; Linhartová, J.; Ort, J. 1977: Functional dependence of prostaglandin F2alpha concentration and plasma renin activity in essential hypertension Casopis Lekaru Ceskych 116(37): 1142-1148
Hayduk, K.; Riegger, G.; Krause, D.K.; Kaufmann, W. 1974: Electrolyte balance, plasma renin concentration and reaction of blood pressure in patients with essential hypertension and control subjects during therapy with metolazone, a new diuretic Arzneimittel-Forschung 24(1): 104-107
Planz, G.; Corr, H.; Gierlichs, H.W.; Hawlina, A.; Planz, R.; Stephany, W.; Rahn, K.H. 1975: Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1066-1068
Kasperska-Zajac, A.; Grzanka, A.; Damasiewicz-Bodzek, A.; Bieniek, K.; Skrzypulec-Frankel, A.; Stencel-Gabriel, K.; Sikora-Zydek, A. 2017: Elevated plasma il-8 concentration is related to severity of systemic inflammation in chronic spontaneous urticaria Journal of Biological Regulators and Homeostatic Agents 31(4): 957-961
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Alexander, R.A.; Lang, C.K.; Steele, M.K.; Corbin, B.J.; Wade, C.E.; Wade, C.E. 1995: Effects of chronic elevated levels of CO2 on the concentration of blood cellular elements and plasma corticosterone in the male rat Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 2(1): P134-P135
Le Quan Sang, K.H.; Montenay-Garestier, T.; Devynck, M.A. 1985: Platelet cytosolic free calcium concentration in essential hypertension Nouvelle Revue Francaise d'Hematologie 27(4): 279-283
Kuroda, T.; Yokoyama, T.; Umeda, T.; Ohnishi, N.; Kuroda, K.; Inoh, T.; Inatome, T.; Yamaguchi, A.; Asada, S. 1985: Pharmacokinetics of nifedipine and prediction of plasma concentration on essential hypertensive patients Kobe Journal of Medical Sciences 31(3): 133-144
Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Tomov, I.; Elenkova, A. 1986: Plasma volume changes in essential hypertension patients Vutreshni Bolesti 25(3): 108-112
Irokawa, N.; Abe, K.; Aoyagi, H.; Memezawa, H.; Yasujima, M. 1973: Plasma renin activity in essential hypertension Nihon Jinzo Gakkai Shi 15(11): 949-960
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Milicević, Z.; Jelaković, B.; Marinković, M. 1994: Hyperuricemia and plasma renin activity in essential arterial hypertension Lijecnicki Vjesnik 116(1-2): 14-17
Buemi, M.; Corica, F.; Squadrito, F.; Ceruso, D.; Frisina, N. 1988: Plasma and erythrocyte magnesium concentrations in essential arterial hypertension Kidney International. Suppl 25: S14-S15
Garcia Zozaya, J.L.; Padilla Viloria, M.; Castro, A. 1987: Essential arterial hypertension: plasma and urinary aldosterone alterations Southern Medical Journal 80(10): 1224-1227
Arakawa, T. 1984: Clinical and experimental studies on elevated plasma level of insulin in cirrhotic patients with portal hypertension and portosystemic collateral circulation Nihon Geka Gakkai Zasshi 85(5): 468-481
Cugini, P.; Serdoz, R.; Manconi, R.; Mancini, A.; Meucci, T. 1978: Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension Bollettino della Societa Italiana di Biologia Sperimentale 54(2): 111-115